HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
NCT07169552
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
NSCLC
Interventions
DRUG:
HC010
Sponsor
HC Biopharma Inc.